Skip to nav Skip to content

Clinical Trial Search

373 Clinical Trials Found

Clinical Trial 21056

A Phase 1b/2, Open-Label, Safety and Efficacy Study of Epcoritamab (GEN3013; DuoBody®-CD3 X CD20) in Relapsed/Refractory Chronic Lymphocytic Leukemia
Disease Site: Lymphoid Leukemia
PI: Sandoval-Sus, Jose

Clinical Trial 21996

An Open-Label, Multicenter, Phase 1b/2 Study of RP1 in Solid Organ Transplant Recipients with Advanced Cutaneous Malignancies
Disease Site: Other Skin
PI: Khushalani, Nikhil

Clinical Trial 20752

A Phase 1 Study of Vyxeos Plus Gilteritinib in Relapsed or Refractory, FLT3-Mutated Acute Myeloid Leukemia
Disease Site: Leukemia, other, Myeloid and Monocytic Leukemia
PI: Chan, Onyee

Clinical Trial 22079

A Phase 1/2, Open-Label Study of PD-1 Knockout Tumor-Infiltrating Lymphocytes (IOC-4001) in Participants with Unresectable or Metastatic Melanoma or Stage III or IV Non-Small-Cell Lung Cancer
Disease Site: Lung, Melanoma, skin
PI: Karapetyan, Lilit

Clinical Trial 90038

Disease Site: Other Hematopoietic
PI: Deutsch, Yehuda

Clinical Trial 23535

Disease Site: Lung
PI: Puri, Sonam

Clinical Trial 23589

A Phase 1, Open-Label Study of ABSK-011 to Assess Safety, Tolerability, and Pharmacokinetics in Patients with Advanced Solid Tumors
Disease Site: Liver
PI: Kim, Richard

Clinical Trial 23660

A Phase 1 Study of MOMA-341 as Monotherapy or Combination Therapy in Participants with Advanced or Metastatic Solid Tumors
Disease Site: Anus, Any Site, Colon, Corpus Uteri, Esophagus, Other Digestive Organ, Rectum
PI: Biachi de Castria, Tiago

Clinical Trial 23766

A First-in-Human Phase 1 Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of FID-022 as Monotherapy in Patients with Advanced Solid Tumors
Disease Site: Anus, Any Site, Breast, Colon, Esophagus, Larynx, Lip, Oral Cavity and Pharynx, Lung, Rectum, Small Intestine, Soft Tissue, Stomach
PI: Rabinowits, Guilherme

Clinical Trial 22005

A Phase 2 Open-Label, Multicenter Study of Rituximab and Zanubrutinib in Patients with indolent B-cell Lymphomas
Disease Site: Non-Hodgkin's Lymphoma
PI: Gaballa, Sameh

Clinical Trial 23319

A Randomized Phase III Trial of Chemo-Immunotherapy vs Immunotherapy Alone for the Vulnerable older adult with Advanced Non-Small Cell Lung Cancer: The ACHIEVE Study
Disease Site: Lung, Non small cell lung cancer
PI: Al-Jumayli, Mohammed

Clinical Trial 23360

IFx-Hu2.0 as an Adjunctive Therapy to Pembrolizumab in Checkpoint Inhibitor Naïve Subjects with Advanced or Metastatic Merkel Cell Carcinoma
Disease Site: Other Skin
PI: Brohl, Andrew